Merck Serono, Neopharma sign deal to develop Merck-branded medication in UAE

By Admin
Merck Serono and Abu-Dhabi-based manufacturing company Neopharma have signed a partnership to develop Merck-branded medication in the UAE for distribut...

Merck Serono and Abu-Dhabi-based manufacturing company Neopharma have signed a partnership to develop Merck-branded medication in the UAE for distribution across the Middle East.

As per the deal, Merck Serono becomes the first multinational pharmaceutical company to work with a local manufacturer to cater to regional demand for the key pharmaceutical products through exports out of the UAE manufacturing base. 

The agreement was signed by Neopharma’s Managing Director and Chief Executive Officer Dr. B.R. Shetty and Merck  Serono CEO Dr Stefan Oschmann.  

The new partnership agreement of Neopharma with Merck Serono comes close on the heels of its collaboration with India’s billion dollar pharmaceutical giant Hetero Group to produce medicines locally.  Both the companies had already signed a joint venture to form a distribution company in the first phase of their partnership.

The newly formed company will distribute Hyderabad-based Hetero’s pharmaceuticals in the UAE.  Initially, the two Merck Serono products will be manufactured by Neopharma: Euthyrox, a hormone therapy requiring a very stringent sterile environment for production and packaging and Glucophage a standard oral treatment for people suffering from type 2 diabetes that helps control blood sugar levels.

The production of both branded medications will begin in 2013.

 Merck Serono is a pharmaceutical company based in Geneva. The company is involved in internal research and development activities and is also involved in publicly funded collaborative research projects with other industrial and academic partners.

Share
Share

Featured Articles

Creating robust pharma supply chains with delivery devices

John Swift, Head of Supply Chain at Owen Mumford Pharmaceutical Services, discusses how lifecycle management is key to a safe supply of pharma products

From Ukraine to Myanmar, reports reveal attacks on hospitals

Reports from the Centre for Information Resilience shows Russian army attacked Ukrainian hospitals & Myanmar’s military Junta targeted medical facilities

The use of AI in biopharma according to L.E.K. Consulting

L.E.K. Consulting’s Stephen Roper & Anne Dhulesia discuss the use of AI in biopharma and unleashing the power of Big Data in the healthcare sector

Novartis Kisqali minimises breast cancer recurrence

Medical Devices & Pharma

Rimidi CEO Lucienne Marie Ide on improving patient outcomes

Hospitals

WatchGuard Technologies & cybersecurity in healthcare

Hospitals